Zum Inhalt springen

Arthritis Consumer Experts & JointHealth™ Programs

@acejointhealth.bsky.social did:plc:ppp37mn2z5srv4cq6fouucqr

JointHealth™ — Your science-based source for easy-to-read arthritis info on treatments, research, and health policy. Visit us at www.jointhealth.org Follow us on Facebook: facebook.com/ACEJointHealth

Bei Bluesky seit

Follower
140
Folgt
61
Posts
293
Tage in Ranglisten
0

Zusammenfassung

Arthritis Consumer Experts & JointHealth™ Programs (@acejointhealth.bsky.social) ist seit 19 November 2024 auf Bluesky. Das Konto hat 140 Follower, folgt 61 Konten und hat 293 Posts veröffentlicht.

Ranglisten-Platzierungen

Die besten Tage, an denen Posts dieses Kontos in Debyas Tagesliste kamen.

Dieses Konto war noch in keiner Tagesrangliste.

Zuletzt gelikte Posts

Öffentliche Likes aus dem Bluesky-Netzwerk.

  • ACR Journals@acr-journals.bsky.social

    Case-cohort study within ELSA-Brasil (N=585) investigated coronary artery calcium (CAC) prevalence in rheumatoid arthritis. RA was not associated with CAC prevalence or incidence, but was associated with greater CAC progression over a 4-year period Arthritis Care & Research doi.org/10.1002/acr....

    Post anzeigen
  • ACR Journals@acr-journals.bsky.social

    Can rheumatoid arthritis remission be predicted using routine baseline data? In 28,900 treatment courses across 11 registries, an externally validated machine learning model showed good rule-out performance but limited gain over logistic regression Arthritis & Rheumatology doi.org/10.1002/art....

    Post anzeigen
  • A Chronic Voice@achronicvoice.com

    "Sometimes I pushed myself to do [the #work ] anyway..just to keep the peace & wound up making myself sick or nearly passing out." (Realities of Trying to Maintain #Employment with a #Disability): buff.ly/PLvijUc by @2HeartCore4U.bsky.social #ChronicIllness #career #workplace #accommodations

    Post anzeigen
  • ACR Journals@acr-journals.bsky.social

    Among 66 patients with Still's disease receiving first-line IL-1 inhibitor therapy, IL-18 levels, particularly at 3 months after IL-1i initiation, could predict long-term disease activity, risk of MAS, & chronic-persistent disease trajectory Arthritis & Rheumatology doi.org/10.1002/art.... #Medsky

    Post anzeigen
  • ACR Journals@acr-journals.bsky.social

    Comparing effects of JAKi on endothelial cell dysfunction & apoptosis showed that despite JAKi protective effects, thrombotic risk factors triggered by TNF & IL-17A persist after treatment with most JAKi. Peficitinib & fedratinib inhibited endothelial cell viability doi.org/10.1002/acr2... #Medsky

    Post anzeigen

Melde dich an, um mehr zu sehen

Blockierte Konten

Blockierungen sind auf Bluesky öffentlich.

Dieses Konto blockiert niemanden.